Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) can cause itching in some people who take it, though for most this is mild and short-lived. Itching most often appears at or near the injection site, particularly in the first few weeks of treatment, and is listed among the known skin-related effects in the medicine's Summary of Product Characteristics. Less commonly, itching can signal an allergic reaction that needs prompt attention. Because tirzepatide is a prescription-only medicine, any skin reaction that concerns you should be discussed with the prescriber who oversees your treatment — they can judge whether to adjust your plan or investigate further. The NHS tirzepatide medicines page lists injection-site reactions and general skin effects among the side effects patients should be aware of.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first practical step when you notice itching on Mounjaro is to identify its location. Run a finger across the area you injected this week, then last week's site, then check anywhere else on your skin. Injection-site reactions (a patch of redness, a raised weal, or an itchy bump) are the most frequently reported skin effects with tirzepatide. They tend to appear within an hour or two of the injection and settle within a day. If the itch is clearly anchored to where you injected, that's reassuring context: localised reactions of this kind are documented in the clinical data and are generally not a reason to stop treatment.
Itching that is spread across your body and has no obvious connection to the injection spot is a different matter. Generalised pruritus (the medical word for itching without a visible rash driving it) is a less common but recognised reaction. It can relate to the immune system adjusting to a new medicine, or occasionally to other factors like dry skin worsened by the reduced appetite and fluid intake some people experience early on. Staying well hydrated matters more than people often realise during the early weeks of treatment.
A quick check worth doing right now: look at your most recent injection site in good light. If there is only a small red mark that is fading, you can note it in a symptom diary and mention it at your next prescriber check-in. If the area is spreading, warm to the touch or increasingly sore, contact your prescriber sooner. If you want a closer look at why Mounjaro can make you itch and the reasons behind it, that page sets out the mechanisms clearly. More detail on the specific patterns people experience is covered on our Mounjaro itchy skin page.
Can Mounjaro make you itchy in a way that signals a real allergy? Yes, though it is uncommon. The distinction between a local injection-site reaction and the early signs of hypersensitivity matters practically.
A local reaction is usually confined to a circle a few centimetres across, fades within 24 hours, and does not spread. An allergic reaction tends to develop more broadly: hives or a raised, blotchy rash beyond the injection area, swelling around the eyes, lips or throat, dizziness, rapid heartbeat, or difficulty breathing. These are signs to treat as a medical emergency. Call 999 or go to A&E rather than waiting for a callback.
Between those two poles sits a middle ground, persistent or worsening skin reactions that are not immediately dangerous but need clinical input. This includes itching that doesn't settle between doses, a rash that spreads beyond the injection site, or new itching that began after a dose increase. Tirzepatide is titrated upward in steps, and some people find that reactions they thought had resolved return when the dose steps up. If that describes your situation, your prescriber can review timing, technique and whether a slower titration schedule is appropriate. Our Mounjaro itching overview covers the full range of presentations in more depth.
A number of injection-site reactions) including itching, are linked to technique rather than the medicine itself. Injecting into the same spot repeatedly concentrates the local response; rotating between the abdomen, thigh and upper arm (and varying within each area) gives tissue time to recover. The needle should be changed with every single injection; reusing a needle blunts the tip, increasing tissue trauma and the chance of a reaction. Swabbing the skin with an alcohol wipe and allowing it to dry fully before injecting also reduces localised irritation.
The pen itself should be stored in the fridge (2–8°C) and allowed to reach room temperature for a few minutes before injecting, a very cold injection can trigger a sharper local response. Exact storage guidance is in your Patient Information Leaflet; follow that rather than any general online advice, since the permitted room-temperature window is specified there precisely.
If you've double-checked your technique and reactions are still bothering you, that's the moment to raise it with your prescriber rather than working around it alone. At nume, a real clinician (not an automated system) handles all clinical queries, and aftercare support is available seven days a week. You can also explore the broader picture of tirzepatide and how it works if you want to understand the pharmacology behind these reactions. For anyone weighing up the full cost picture of treatment alongside these practical considerations, our Mounjaro pricing page sets out what a private prescription typically includes.
The MHRA's Yellow Card scheme exists so that patients can report unexpected or troubling side effects directly; doing so helps regulators track emerging patterns across the population. If you experience itching or skin reactions that feel unusual or severe, you can file a report at yellowcard.mhra.gov.uk, this is separate from, and in addition to, contacting your prescriber.
For reactions that are uncomfortable but not urgent, a symptom diary is your best tool: note the date, the dose you're on, where the itching appeared, how long it lasted, and whether anything seemed to help or worsen it. That record gives your prescriber something concrete to work from rather than a vague recollection. Some people find that a non-sedating antihistamine helps with mild itching between prescriber reviews, but check with your prescriber or pharmacist before taking one, as interactions and suitability vary by individual.
If you have specific concerns about itching in a particular area (scalp reactions, for instance, are a distinct presentation with their own pattern) our Mounjaro itchy scalp page addresses those directly. And if you have questions about starting treatment or are curious whether Mounjaro might be suitable for you, the nume FAQs are a useful first stop before a consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.